Back

Hematologist perspective: what is the standard in cardiotoxicity stratification? Is it enough?

19 June 2026 (14:20 - 14:30)
Organised by: Logo
Congress Presentation Part of: RESILIENCE project: cardiovascular toxicity in onco-hematology trials Cardio-Oncology Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Vincent Camus

Centre Henri Becquerel, Rouen (France)

4 More presentations in this session

Presentation thumbnail
Cardiologist perspective. What is needed?
Doctor M. Andres (London, GB)
Slides Video
Presentation thumbnail
Regulator perspective
Mr I. Pinedo Garcia (Madrid, ES)
Slides Video
Presentation thumbnail
Patient perspective
Mr A. Navarro Jarava (ES)
Slides Video
Presentation thumbnail
Cardiovascular toxicity in onco-hematology trials - discussion
Video

Access the full session

Session thumbnail
RESILIENCE project: cardiovascular toxicity in onco-hematology trials
Video

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 14:20 CET
You may be interested in
thumbnail
Congress Presentation
Can my patient with heart failure get anthracycline therapy?
thumbnail
Congress Presentation
Why, when, and how to prevent cardiotoxicity? gaps in knowledge
thumbnail
Congress Presentation
State-of-the-art lecture on prediction and management of cardiovascular risk in cancer patients

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources